Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Nabi enters agreement with Diosynth for manufacture of NicVAX nicotine vaccine

Sep. 7, 2010

MSD and Faes Farma to market sitagliptin and sitagliptin/metformin in Spain

Sep. 6, 2010

Ipsen gains rights to fipamezole outside of North America and Japan

Sep. 3, 2010

iBio, Fraunhofer and GE Healthcare to partner for iBioLaunch platform

Sep. 3, 2010

Orexigen and Takeda to co-commercialize Contrave in North America

Sep. 3, 2010

MorphoSys and Absynth partner for MRSA treatments

Sep. 3, 2010

HUYA and Sun Yat-sen University to develop novel drugs in China

Sep. 2, 2010

Ono receives exclusive rights in Japan to salirasib

Sep. 2, 2010

IntelGenx and RedHill sign agreement for migraine film product

Sep. 2, 2010

BTG to receive marketing rights for Nycomed's CroFab and DigiFab

Sep. 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...